DEA Application

Registration Services

End-to-End Regulatory guidance, documentation prep, and compliance consulting for businesses navigating DEA registration requirements.

A Complex Federal Filing Requires Elite Execution DEA Schedule III registration is not a simple form submission—it requires rigorous facility documentation, stringent security audits, and flawless regulatory alignment. Whether you need a complete application build-out, an operational gap assessment, or long-term compliance strategies, CannDelta provides a clear, actionable path to federal standing.

State Mandates Are Forcing Immediate Action: The regulatory landscape is shifting rapidly. We navigate the complexities of specific state jurisdictions so you don’t have to:

  • Oklahoma Operators: The OBNDD now mandates federal DEA registration. We secure your federal filing to protect your state operating credentials.

  • California Operators: We fast-track DCC “M” (Medicinal) designation upgrades, allowing commercial operators to restructure and unlock vital IRS Section 280E tax exemptions.

Register Your Business with the DEA. Deadline is Fast Approaching

How Is CannDelta Helping DEA Applicants

DEA Schedule III is here. Most consultants will help you fill out Form 225 and call it done. We are doing the registration, and we are building the operational backbone that keeps you compliant from day one of inspection forward.

Here is what CannDelta is delivering for our DEA clients right now:

  1. Form 225 registration, prepared and submitted. Cultivation, manufacturing, and where it applies, distributor activities. The application is the easy part. We make sure the case behind it holds up.
  2. Federal SOPs, built for DEA inspectors. Separate from your state SOPs. Written to 21 CFR standards. Ready for a diversion investigator to read on day one.
  3. Gap analysis against DEA security and recordkeeping standards. Most cultivators are built for state inspectors. The federal bar is different. We tell you where you are short before the DEA does.
  4. Recordkeeping infrastructure aligned to 21 CFR 1304. Inventory logs, vendor tracking, product records, and the paper trail that has to exist before product moves. Built to survive an audit, not just pass a registration.
  5. Physical security plans to 21 CFR 1301.71-76. Vaults, intrusion detection, surveillance, restricted access. The architecture and the narrative document that pairs with it. This is what the pre-registration inspector reads before they walk your facility.

And we are preparing you for the global market.

Once Schedule III opens federal export pathways, GACP and EU-GMP readiness become the next bottleneck. We do not just fill out forms. We compile, draft, complete, submit, and support the documents through to the response, whether that is from the DEA, from a GACP certification body, or from a foreign competent authority. Your file is our file until the decision comes back.

This is the work that separates operators who treat Schedule III as a finish line from those who treat it as a starting line.

CannDelta is building for both.

Who We Are ?

Over 450 Regulated Businesses Successfully Launched

CannDelta Team Picture with all members

CannDelta Inc. is a regulatory licensing, operations, and marketing firm based in Lower Manhattan. Over the past eight years, CannDelta has coached entrepreneurs and helped launch more than 450 regulated businesses nationwide. We help small businesses navigate every stage of growth — from securing licenses and completing full build-outs to developing operational procedures, digital marketing and sales strategies, and brand launches.

At CannDelta, our goal is to empower new and established companies in the industry to become not just sustainable but successful by delivering our expertise. We support entrepreneurs through licensing hurdles and with their operational and regulatory burdens. We conduct relevant market research, and assist with crucial strategic business planning.

As Quoted In

Frequently Asked Questions About DEA Schedule 3

Businesses that miss the deadline lose a lot of the protections that are provided by the expedited application window. That includes no guaranteed review timeline (late applications could take months or years to review), no operating continuity protection, and losing the first mover advantages provided by a federal medical market

No. The Schedule III designation and the expedited federal registration pathway strictly apply to FDA-approved drug and regulated products and subject to a state medical regulated license. Registrations under this new subpart do not authorize the manufacture, distribution, or dispensing of regulated products for non-medical or recreational purposes. Adult-use remains a Schedule I controlled substance.

The DEA has established an expedited “Fast-Track” review process for entities holding state medical licenses. The agency aims to process applications submitted within 60 days of the rule’s publication (by June 27, 2026) within six months. Crucially, businesses that apply within this 60-day window can lawfully continue operations under their state licenses while the DEA reviews their application.

Because the United States must comply with the Single Convention on Narcotic Drugs, the federal government must maintain a monopoly on the wholesale trade of regulated product. To satisfy this, registered manufacturers must establish a nominal price for their crops. The DEA will then technically “purchase” the crop and immediately “sell” it back to the manufacturer with a small administrative fee added. 

Generally, yes. To reduce the federal regulatory burden, the DEA allows registrants to rely heavily on existing state laws. You are considered compliant with federal Schedule III standards for physical security, packaging, labeling, and disposal as long as you meet the requirements of your state law. The only major addition is that your labeling must now include the statutory federal warning label.

The DEA has established an expedited “Fast-Track” review process for entities holding state medical licenses. The agency aims to process applications submitted within 60 days of the rule’s publication (by June 27, 2026) within six months. Crucially, businesses that apply within this 60-day window can lawfully continue operations under their state licenses while the DEA reviews their application.

If you submit your DEA registration application within the 60-day window (by June 27, 2026), the DEA allows you to **continue manufacturing, distributing, and dispensing medical regulated product in conformity with your state-issued license during the pendency of the application**. Because you are permitted to operate under your existing state regulations while the DEA reviews your file (which they aim to complete within six months for early applicants who register in the 60 day window ending June 27), this serves as your operational transition period.

Additionally, as long as the State you’re operating in does not make DEA registration a requirement, then you can continue operating your statewide medical business with state approved suppliers that are not DEA registered.

That being said, your supply chain must ultimately transition to full federal compliance. The 7-step DEA application explicitly requires you to **provide the name and DEA registration number for each supplier from which your firm intends to procure marijuana products**. Furthermore, the final rule clearly outlines the federal supply chain, noting that registered distributors may only receive products from registered manufacturers. 

Therefore, while you can lawfully operate under your state license and utilize your current supply chain while your application is pending, your producers will need to secure their own DEA registrations concurrently so that you can list their DEA numbers to finalize your own federal compliance.

Connect with CannDelta

The expedited window closes on June 27. Don’t lose your spot in the queue. Connect with CannDelta Experts Today!